Fullerenol C60(OH)24 nanoparticles decrease relaxing effects of dimethyl sulfoxide on rat uterus spontaneous contraction
Source abstract
Abstract
Dimethyl sulfoxide (DMSO) is a widely used solvent and cryoprotectant that can cause impaired blood flow, reduction in intracranial pressure, tissue edema, inflammatory reactions, inhibition of vascular smooth muscle cell migration and proliferation, processes which can lead to atherosclerosis of the coronary, peripheral and cerebral circulation. Although the adverse effects are rare when DMSO is administered in clinically established concentrations, there is no safe antagonist for an overdose. In this work, we treated isolated spontaneous and calcium-induced contractile active rat uteri (Wistar, virgo intacta), with DMSO and fullerenol C60(OH)24 nanoparticle (FNP) in DMSO. FNP is a water-soluble derivative of fullerene C60. Its size is a 1.1 nm in diameter and is a very promising candidate for a drug carrier in nanomedicine. FNP also displays free radical scavenging activity. DMSO decreased both spontaneous and calcium-induced contractions. In contrast, FNP only decreased spontaneous contraction. FNP decreased copper–zinc superoxide dismutase activity and prevented the DMSO-induced increase in glutathione reductase activity. Atomic force microscopy detected that FNP aggregated with calcium ions. Our results indicate that FNP has properties that make it a good candidate to be a modulator of DMSO activity which could minimize side effects of the latter.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Fullerene Chemistry and Applications · Anesthesia and Neurotoxicity Research · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (36)
Show source-provided references
1. Ali SS, Hardt JI, Quich KL, Kim-Han JS, Erlanger BF, Huang TT, Epstein CJ, Dugan LL (2004) A biologically effective fullerene (C60) derivative with superoxide dismutase mimetic properties. Free Radic Biol Med 37(8):1191–1202. doi: 10.1016/j.freeradbiomed.2004.07.00210.1016/j.freeradbiomed.2004.07.002 ↗
2. Appiah I, Milovanovic S, Radojicic R, Nikolic-Kokic A, Orescanin-Dusic Z, Slavic M, Trbojevic S, Skrbic R, Spasic MB, Blagojevic D (2009) Hydrogen peroxide affects contractile activity and anti-oxidant enzymes in rat uterus. Br J Pharmacol 158(8):1932–1941. doi: 10.1111/j.1476-5381.2009.00490.x10.1111/j.1476-5381.2009.00490.x ↗
3. Birder LA, Kanai AJ, de Groat WC (1997) DMSO: effect on bladder afferent neurons and nitric oxide release. J Urol 158:1989–1995. doi: 10.1016/S0022-5347(01)64199-510.1016/S0022-5347(01)64199-5 ↗
4. Brant JA, Labile J, Robichaund CO, Wiesner M (2007) Fullerol cluster formation in aqueous solutions: implications for environmental release. J Colloid Interface Sci 314:281–288. doi: 10.1016/j.jcis.2007.05.02010.1016/j.jcis.2007.05.020 ↗
5. Calvaresi M, Falini G, Bonacchi S, Genovese D, Fermani S, Montalti M, Prodi L, Zerbetto F (2011) Fullerenol entrapment in calcite microspheres. Chem Commun (Camb) 47(38):10662–10664. doi: 10.1039/C1CC13680A10.1039/c1cc13680a ↗
6. Dittrich R, Maltaris T, Mueller A, Dimmler A, Hoffmann I, Kiesewetter F, Beckmann MW (2006) Successful uterus cryopreservation in an animal model. Horm Metab Res 38(3):141–145. doi: 10.1055/s-2006-92517510.1055/s-2006-925175 ↗
7. Djordjevic A, Vojinovic-Mloradov M, Petranovic N, Devcerski A, Layar D, Ribar B (1998) Catalytical preparation and characterization of S60Br24. Fullerene Sci Technol 6:689–694. doi: 10.1080/1064122980935022910.1080/10641229809350229 ↗
8. Dragojevic-Simic V, Jacevic V, Dobric S, Djordjevic A, Bokonjic D, Bajcetic M, Injac R (2011) Anti-inflammatory activity of fullerenol C60(OH)24 nano-particles in a model of acute inflammation in rats. Dig J Nanomater Biostruct 6:819–827
9. Fageeh W, Raffa H, Jabbad H, Marzouki A (2002) Transplantation of the human uterus. Int J Gynecol Obstet 76(3):245–251. doi: 10.1016/S0020-7292(01)00597-510.1016/S0020-7292(01)00597-5 ↗
10. Fahy GM (2010) Cryoprotectant toxicity neutralization. Cryobiology 60:S45–S5310.1016/j.cryobiol.2009.05.005 ↗
11. Fenech M (2002) Chromosomal biomarkers of genomic instability relevant to cancer. Drug Discov Today 7(22):1128–113710.1016/S1359-6446(02)02502-3 ↗
12. Gelderman MP, Simakova O, Clogston JD, Patri AK, Siddiqui SF, Vostal AC, Simak J (2008) Adverse effect of fullerenes on endothelial cells: fullerenol C60(OH)24 induced tissue factor and ICAM-1 membrane expression and apoptosis in vitro. Int J of Nanomed 3(1):59–68
13. Glatzle D, Vuilleumier JP, Weber F, Decker K (1974) Glutathione reductase test with whole blood a convenient procedure for the assessment of the riboflavin status in humans. Experimetria 30:665–66810.1007/BF01921531 ↗
14. Grynberg M, Ayoubi J-M, Bulletti C, Frydman R, Franchin R (2011) Uterine transplantation: a promising surrogate to surrogacy? Reprod Sci 1221:47–53
15. Hinkle ED, Wiersma W, Jurs GS (1994) Applied statistics for behavioral sciences. Houghton Mifflin Company, Boston
16. Hollebeeck S, Raas T, Piront N, Schneider YJ, Toussaint O, Larondelle Y, During A (2011) Dimethyl sulfoxide (DMSO) attenuates the inflammatory response in the in vitro intestinal Caco-2 cell model. Toxicol Lett 206(3):268–275. doi: 10.1016/j.toxlet.2011.08.01010.1016/j.toxlet.2011.08.010 ↗
17. Homer ZN, Reglinski J, Sowden R, Spickett CM, Wilson R, Walker JJ (2005) Dimethylsulfoxide oxidizes glutathione in vitro and in human erythrocytes: kinetic analysis by 1H NMR. Cryobiology 50:317–324. doi: 10.1016/j.cryobiol.2005.04.00210.1016/j.cryobiol.2005.04.002 ↗
18. Injac R, Radic N, Govedarica B, Djordjevic A, Strukelj B (2008) Bioapplication and activity of fullerenol C60(OH)24. Afr J Biotechnol 7(25):4050–4940
19. Kloesch B, Liszt M, Broell J, Steiner G (2011) Dimethyl sulphoxide and dimethyl sulphone are potent inhibitors of IL-6 and IL-8 expression in the human chondrocyte cell line C-28/I2. Life Sci 89(13-14):473–478. doi: 10.1016/j.lfs.2011.07.01510.1016/j.lfs.2011.07.015 ↗
20. Manley BFJ (1986) Multivariate statistical methods. Chapman & Hall, London
21. Marcondes FK, Bianchi FI, Tanno AP (2002) Determination of the estrous cycle phases of rats: some helpful considerations. Braz J Biol 62:609–614. doi: 10.1590/S1519-6984200200040000810.1590/S1519-69842002000400008 ↗
22. Mariano AC, Alexandre GM, Silva LC, Romeiro A, Cameron LC, Chen Y, Chase PB, Sorenson MM (2001) Dimethyl sulphoxide enhances the effects of P(i) in myofibrils and inhibits the activity of rabbit skeletal muscle contractile proteins. Biochem J 358:627–636. doi: 10.1042/0264-6021:358062710.1042/0264-6021:3580627 ↗
23. Marren K (2011) Dimethyl sulfoxide: an effective penetration enhancer for topical administration of NSAIDs. Phys Sportsmed 39(3):75–82. doi: 10.3810/psm.2011.09.192310.3810/psm.2011.09.1923 ↗
24. Mirkov SM, Djordjevic AN, Andric NL, Andric SA, Kostic TS, Bogdanovic GM, Vojinovic-Miloradov MB, Kovacevic RZ (2004) Nitric oxide-scavenging activity of polyhydroxylated fullerenol, C60(OH)24. Nitric Oxide 11(2):201–20710.1016/j.niox.2004.08.003 ↗
25. Misra HP, Fridovich I (1972) The role of superoxide anion in the autooxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 247(10):3170–317510.1016/S0021-9258(19)45228-9 ↗
26. Mrdjanovic J, Solajic S, Bogdanovic V, Stankov K, Bogdanovic G, Djordjevic A (2009) Effects of fullerenol C60(OH)24 on the frequency of micronuclei and chromosome aberrations in CHO-K1 cells. Mutat Res 680:25–3010.1016/j.mrgentox.2009.08.008 ↗
27. Mrdjanovic JZ, Solajic SV, Bogdanovic VV, Stankov K, Djordjevic AN, Bogdanovic GM, Injac RD, Rakocevic ZLJ (2012) Effects of fullerenol nano particles C60 (OH)24 on micronuclei and chromosomal aberrations’ frequency in peripheral blood lymphocytes. Dig J Nanomater Bios 7(2):673–686
28. Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:74–77
29. Parkin J, Shea C, Sant GR (1997) Intravesical dimethyl sulfoxide (DMSO) for interstitial cystitis-a practical approach. Urology 49(5, Suppl):105–107. doi: 10.1016/S0090-4295(97)00181-710.1016/S0090-4295(97)00181-7 ↗
30. Partha R, Conyers JL (2009) Biomedical applications of functionalized fullerene-based nanomaterials. Int J Nanomed 4:261–27510.2217/nnm.09.11 ↗
31. Pinteala M, Dascalu A, Ungurenasu C (2009) Binding fullerenol C60(OH)24 to dsDNA. Int J Nanomed 4:193–19910.2217/17435889.4.2.193 ↗
32. Rall WF, Fahy GM (1985) Ice-free cryopreservation of mouse embryos at −196 degrees C by vitrification. Nature 313(6003):573–575. doi: 10.1038/313573a010.1038/313573a0 ↗
33. Salmen JJ, Skufca F, Matt A, Gushansky G, Mason A, Gardiner CS (2005) Role of glutathione in reproductive tract secretion on mouse preimplantation embryo development. Biol Reprod 73:308–314. doi: 10.1095/biolreprod.104.03830710.1095/biolreprod.104.038307 ↗
34. Satoh M, Takayanagi I (2006) Pharmacological studies on fullerene (C60), a novel carbon allotrope, and its derivatives. J Pharmacol Sci 100:513–518. doi: 10.1254/jphs.CPJO6OO2X10.1254/jphs.CPJ06002X ↗
35. Shiga KI, Hirano K, Nishimura J, Niiro N, Kanaide H (2007) Dimethyl sulphoxide relaxes rabbit detrusor muscle by decreasing the Ca+2 sensitivity of the contractile apparatus. Br J Pharmacol 151(7):1014–102410.1038/sj.bjp.0707317 ↗
36. Tsai MC, Chen YH, Chiang LY (1997) Polyhydroxylated C60 fullerenol, a novel free radical trapper, prevented hydrogen peroxide- and cumene hydroperoxide-elicited changes in rat hippocampus in vitro. J Pharm Pharmacol 49:438–445. doi: 10.1111/j.2042-7158.1997.tbO6821.x10.1111/j.2042-7158.1997.tb06821.x ↗